PDHK3
TYR version of PSPA with Y as phospho-acceptor
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A2RRP1 | S473 | Sugiyama | NBAS NAG | APKRSRLETRAGEEDEGEEDsDsDyEISAKARYFGYIKQGL |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| P00533 | Y764 | Sugiyama | EGFR ERBB ERBB1 HER1 | IKELREATSPKANKEILDEAyVMAsVDNPHVCRLLGICLTS |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08559 | S232 | SIGNOR|iPTMNet | PDHA1 PHE1A | ALWKLPCIFICENNRYGMGtsVERAAAsTDYYKRGDFIPGL |
| P08559 | S293 | GPS6|SIGNOR|ELM|iPTMNet|PSP | PDHA1 PHE1A | CRSGKGPILMELQTYRyHGHsMsDPGVsyRtREEIQEVRsK |
| P08559 | S300 | GPS6|SIGNOR|ELM|PSP | PDHA1 PHE1A | ILMELQTYRyHGHsMsDPGVsyRtREEIQEVRsKsDPIMLL |
| P08865 | Y156 | Sugiyama | RPSA LAMBR LAMR1 | EAsyVNLPtIALCNTDSPLRyVDIAIPCNNKGAHSVGLMWW |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P12277 | S164 | Sugiyama | CKB CKBB | PHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAEQ |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P23193 | Y177 | Sugiyama | TCEA1 GTF2S TFIIS | DYIAIGADEEELGSQIEEAIyQEIRNTDMKYKNRVRSRISN |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P29803 | S291 | SIGNOR|PSP | PDHA2 PDHAL | CRSGKGPILMELQTYRyHGHsMsDPGVsyRtREEIQEVRsK |
| P29803 | S298 | PSP | PDHA2 PDHAL | ILMELQTYRyHGHsMsDPGVsyRtREEIQEVRsKRDPIIIL |
| P31946 | S60 | GPS6 | YWHAB | NEERNLLsVAyKNVVGARRSsWRVIsSIEQKTERNEKKQQM |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q04917 | S59 | GPS6 | YWHAH YWHA1 | NEDRNLLsVAyKNVVGARRSsWRVIsSIEQKTMADGNEKKL |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q15120 | S25 | Sugiyama | PDK3 PDHK3 | RWLLKQPVPKQIERYSRFsPsPLSIKQFLDFGRDNACEKTS |
| Q15120 | S390 | Sugiyama | PDK3 PDHK3 | PVFNKSAWRHYKttPEADDWsNPssEPRDASKYKAKQ____ |
| Q15120 | S393 | Sugiyama | PDK3 PDHK3 | NKSAWRHYKttPEADDWsNPssEPRDASKYKAKQ_______ |
| Q15120 | S394 | Sugiyama | PDK3 PDHK3 | KSAWRHYKttPEADDWsNPssEPRDASKYKAKQ________ |
| Q15120 | T382 | Sugiyama | PDK3 PDHK3 | SSESFERLPVFNKSAWRHYKttPEADDWsNPssEPRDASKY |
| Q15120 | T383 | Sugiyama | PDK3 PDHK3 | SESFERLPVFNKSAWRHYKttPEADDWsNPssEPRDASKYK |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9NYF8 | Y383 | Sugiyama | BCLAF1 BTF KIAA0164 | EKGSEKGRAEGEWEDQEALDyFsDKEsGKQKFNDsEGDDtE |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Interferon alpha/beta signaling | R-HSA-909733 | 0.001566 | 2.805 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 0.002730 | 2.564 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 0.003434 | 2.464 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 0.006245 | 2.204 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 0.005993 | 2.222 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 0.005911 | 2.228 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 0.005067 | 2.295 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 0.005067 | 2.295 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 0.008156 | 2.089 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 0.008056 | 2.094 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 0.010649 | 1.973 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 0.018824 | 1.725 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 0.018824 | 1.725 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 0.018824 | 1.725 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 0.018824 | 1.725 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 0.018824 | 1.725 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 0.015202 | 1.818 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 0.016702 | 1.777 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 0.014471 | 1.840 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 0.014387 | 1.842 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 0.018936 | 1.723 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 0.046403 | 1.333 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 0.046403 | 1.333 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 0.055424 | 1.256 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 0.064359 | 1.191 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 0.064359 | 1.191 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 0.064359 | 1.191 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 0.073211 | 1.135 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 0.073211 | 1.135 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 0.107794 | 0.967 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 0.107794 | 0.967 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 0.029565 | 1.529 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 0.132887 | 0.877 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 0.149225 | 0.826 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 0.173161 | 0.762 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 0.173161 | 0.762 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 0.180989 | 0.742 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 0.188745 | 0.724 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 0.196427 | 0.707 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 0.074223 | 1.129 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 0.204037 | 0.690 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 0.204037 | 0.690 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 0.219042 | 0.659 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 0.042727 | 1.369 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 0.226439 | 0.645 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 0.226439 | 0.645 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 0.233767 | 0.631 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 0.241026 | 0.618 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 0.241026 | 0.618 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 0.055172 | 1.258 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 0.111891 | 0.951 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 0.124312 | 0.905 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 0.130642 | 0.884 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 0.269383 | 0.570 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 0.269383 | 0.570 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 0.133834 | 0.873 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 0.133834 | 0.873 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 0.276306 | 0.559 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 0.276306 | 0.559 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 0.276306 | 0.559 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 0.276306 | 0.559 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 0.289958 | 0.538 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 0.296687 | 0.528 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 0.296687 | 0.528 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 0.020786 | 1.682 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 0.309957 | 0.509 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 0.309957 | 0.509 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 0.316498 | 0.500 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 0.186923 | 0.728 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 0.277395 | 0.557 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 0.296687 | 0.528 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 0.196427 | 0.707 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 0.316498 | 0.500 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 0.149225 | 0.826 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 0.283164 | 0.548 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 0.044264 | 1.354 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 0.046545 | 1.332 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 0.322978 | 0.491 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 0.116238 | 0.935 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 0.076950 | 1.114 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 0.102807 | 0.988 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 0.248216 | 0.605 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 0.116238 | 0.935 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 0.124602 | 0.904 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 0.165257 | 0.782 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 0.055424 | 1.256 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 0.141095 | 0.850 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 0.141095 | 0.850 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 0.141095 | 0.850 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 0.204037 | 0.690 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 0.173355 | 0.761 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 0.289958 | 0.538 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 0.027660 | 1.558 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 0.020570 | 1.687 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 0.107794 | 0.967 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 0.082773 | 1.082 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 0.322978 | 0.491 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 0.165257 | 0.782 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 0.309957 | 0.509 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 0.291406 | 0.536 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 0.305384 | 0.515 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 0.270383 | 0.568 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 0.024601 | 1.609 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 0.309957 | 0.509 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 0.055424 | 1.256 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 0.064359 | 1.191 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 0.180989 | 0.742 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 0.196427 | 0.707 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 0.204037 | 0.690 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 0.255338 | 0.593 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 0.140272 | 0.853 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 0.166634 | 0.778 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 0.322978 | 0.491 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 0.259862 | 0.585 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 0.319312 | 0.496 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 0.167334 | 0.776 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 0.211575 | 0.675 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 0.090666 | 1.043 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 0.116238 | 0.935 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 0.121176 | 0.917 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 0.303354 | 0.518 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 0.176731 | 0.753 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 0.316498 | 0.500 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 0.044264 | 1.354 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 0.064359 | 1.191 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 0.064864 | 1.188 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 0.053640 | 1.271 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 0.276306 | 0.559 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 0.283164 | 0.548 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 0.322978 | 0.491 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 0.157279 | 0.803 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 0.309957 | 0.509 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 0.063685 | 1.196 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 0.063685 | 1.196 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 0.063685 | 1.196 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 0.065564 | 1.183 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 0.262394 | 0.581 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 0.256356 | 0.591 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 0.222526 | 0.653 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 0.296687 | 0.528 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 0.157279 | 0.803 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 0.322978 | 0.491 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 0.165257 | 0.782 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 0.219042 | 0.659 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 0.322978 | 0.491 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 0.105167 | 0.978 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 0.192244 | 0.716 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 0.055424 | 1.256 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 0.099271 | 1.003 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 0.099271 | 1.003 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 0.141095 | 0.850 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 0.165257 | 0.782 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 0.173161 | 0.762 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 0.173161 | 0.762 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 0.173161 | 0.762 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 0.233767 | 0.631 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 0.111891 | 0.951 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 0.140272 | 0.853 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 0.077821 | 1.109 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 0.053640 | 1.271 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 0.117351 | 0.931 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 0.107794 | 0.967 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 0.113033 | 0.947 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 0.084553 | 1.073 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 0.136064 | 0.866 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 0.207759 | 0.682 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 0.073211 | 1.135 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 0.116238 | 0.935 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 0.137045 | 0.863 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 0.309957 | 0.509 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 0.180119 | 0.744 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 0.155512 | 0.808 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 0.204081 | 0.690 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 0.155020 | 0.810 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 0.138226 | 0.859 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 0.238848 | 0.622 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 0.091905 | 1.037 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 0.216515 | 0.665 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 0.173355 | 0.761 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 0.183516 | 0.736 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 0.110023 | 0.959 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 0.255338 | 0.593 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 0.269383 | 0.570 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 0.143516 | 0.843 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 0.255338 | 0.593 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 0.107794 | 0.967 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 0.226439 | 0.645 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 0.124312 | 0.905 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 0.269383 | 0.570 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 0.022786 | 1.642 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 0.211575 | 0.675 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 0.204081 | 0.690 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 0.248216 | 0.605 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 0.248216 | 0.605 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 0.322978 | 0.491 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 0.219042 | 0.659 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 0.219042 | 0.659 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 0.275595 | 0.560 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 0.275595 | 0.560 | 0 | 0 |
| S Phase | R-HSA-69242 | 0.210205 | 0.677 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 0.157279 | 0.803 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 0.255338 | 0.593 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 0.269383 | 0.570 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 0.315836 | 0.501 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 0.085316 | 1.069 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 0.269383 | 0.570 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 0.277395 | 0.557 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 0.233767 | 0.631 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 0.289958 | 0.538 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 0.070927 | 1.149 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 0.141095 | 0.850 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 0.149225 | 0.826 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 0.211575 | 0.675 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 0.226439 | 0.645 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 0.248216 | 0.605 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 0.255338 | 0.593 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 0.255338 | 0.593 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 0.312355 | 0.505 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 0.262394 | 0.581 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 0.137045 | 0.863 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 0.321112 | 0.493 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 0.321112 | 0.493 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 0.262394 | 0.581 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 0.088915 | 1.051 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 0.169988 | 0.770 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 0.048869 | 1.311 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 0.226439 | 0.645 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 0.031638 | 1.500 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 0.141095 | 0.850 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 0.255338 | 0.593 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 0.322978 | 0.491 | 0 | 0 |
| Immune System | R-HSA-168256 | 0.071784 | 1.144 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 0.099361 | 1.003 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 0.116238 | 0.935 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 0.309957 | 0.509 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 0.027527 | 1.560 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 0.222526 | 0.653 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 0.061088 | 1.214 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 0.255338 | 0.593 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 0.197195 | 0.705 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 0.195635 | 0.709 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 0.027527 | 1.560 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 0.165257 | 0.782 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 0.099827 | 1.001 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 0.022786 | 1.642 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 0.230092 | 0.638 | 1 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 0.180119 | 0.744 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 0.253611 | 0.596 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 0.188745 | 0.724 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 0.188745 | 0.724 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 0.051234 | 1.290 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 0.149225 | 0.826 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 0.273889 | 0.562 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 0.124602 | 0.904 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 0.072572 | 1.139 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 0.093942 | 1.027 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 0.242445 | 0.615 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 0.248216 | 0.605 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 0.274589 | 0.561 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 0.245047 | 0.611 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 0.153340 | 0.814 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 0.183720 | 0.736 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 0.125438 | 0.902 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 0.149207 | 0.826 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 0.280900 | 0.551 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 0.181332 | 0.742 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 0.190338 | 0.720 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 0.231861 | 0.635 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 0.329397 | 0.482 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 0.329397 | 0.482 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 0.334977 | 0.475 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 0.335755 | 0.474 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 0.335755 | 0.474 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 0.335755 | 0.474 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 0.335755 | 0.474 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 0.335755 | 0.474 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 0.335755 | 0.474 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 0.339241 | 0.469 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 0.340076 | 0.468 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 0.342053 | 0.466 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 0.342053 | 0.466 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 0.342053 | 0.466 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 0.342053 | 0.466 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 0.345326 | 0.462 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 0.346957 | 0.460 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 0.348292 | 0.458 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 0.348292 | 0.458 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 0.348292 | 0.458 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 0.350496 | 0.455 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 0.351159 | 0.454 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 0.354472 | 0.450 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 0.354472 | 0.450 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 0.354472 | 0.450 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 0.354472 | 0.450 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 0.354472 | 0.450 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 0.357233 | 0.447 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 0.360594 | 0.443 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 0.360594 | 0.443 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 0.360594 | 0.443 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 0.360594 | 0.443 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 0.360594 | 0.443 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 0.360594 | 0.443 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 0.360594 | 0.443 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 0.360594 | 0.443 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 0.360594 | 0.443 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 0.360594 | 0.443 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 0.360594 | 0.443 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 0.360594 | 0.443 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 0.360594 | 0.443 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 0.360823 | 0.443 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 0.366658 | 0.436 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 0.366658 | 0.436 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 0.366658 | 0.436 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 0.366658 | 0.436 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 0.367451 | 0.435 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 0.372665 | 0.429 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 0.372665 | 0.429 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 0.372665 | 0.429 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 0.372665 | 0.429 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 0.372665 | 0.429 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 0.372665 | 0.429 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 0.372665 | 0.429 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 0.374229 | 0.427 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 0.378616 | 0.422 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 0.378616 | 0.422 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 0.378616 | 0.422 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 0.384340 | 0.415 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 0.384510 | 0.415 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 0.384510 | 0.415 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 0.384510 | 0.415 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 0.390048 | 0.409 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 0.390349 | 0.409 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 0.390349 | 0.409 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 0.391042 | 0.408 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 0.391042 | 0.408 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 0.396133 | 0.402 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 0.396133 | 0.402 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 0.396133 | 0.402 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 0.396133 | 0.402 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 0.397584 | 0.401 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 0.401035 | 0.397 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 0.401862 | 0.396 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 0.401862 | 0.396 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 0.401862 | 0.396 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 0.401862 | 0.396 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 0.401862 | 0.396 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 0.401862 | 0.396 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 0.401862 | 0.396 | 1 | 0 |
| Synthesis of PC | R-HSA-1483191 | 0.407538 | 0.390 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 0.410951 | 0.386 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 0.413159 | 0.384 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 0.413159 | 0.384 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 0.414238 | 0.383 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 0.414518 | 0.382 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 0.418728 | 0.378 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 0.418728 | 0.378 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 0.424245 | 0.372 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 0.434627 | 0.362 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 0.435122 | 0.361 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 0.436992 | 0.360 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 0.440483 | 0.356 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 0.440483 | 0.356 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 0.440483 | 0.356 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 0.445795 | 0.351 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 0.449780 | 0.347 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 0.451056 | 0.346 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 0.451338 | 0.345 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 0.456267 | 0.341 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 0.456267 | 0.341 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 0.456267 | 0.341 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 0.461429 | 0.336 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 0.462405 | 0.335 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 0.466543 | 0.331 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 0.469112 | 0.329 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 0.471608 | 0.326 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 0.471608 | 0.326 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 0.471608 | 0.326 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 0.471762 | 0.326 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 0.476626 | 0.322 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 0.477947 | 0.321 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 0.481022 | 0.318 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 0.481596 | 0.317 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 0.486101 | 0.313 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 0.486117 | 0.313 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 0.486520 | 0.313 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 0.486520 | 0.313 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 0.487141 | 0.312 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 0.487141 | 0.312 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 0.490183 | 0.310 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 0.491396 | 0.309 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 0.491396 | 0.309 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 0.491396 | 0.309 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 0.491396 | 0.309 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 0.493294 | 0.307 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 0.496227 | 0.304 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 0.496234 | 0.304 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 0.499243 | 0.302 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 0.501013 | 0.300 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 0.502240 | 0.299 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 0.505226 | 0.297 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 0.505226 | 0.297 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 0.505753 | 0.296 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 0.510448 | 0.292 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 0.510448 | 0.292 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 0.515099 | 0.288 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 0.515099 | 0.288 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 0.515099 | 0.288 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 0.524270 | 0.280 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 0.524270 | 0.280 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 0.528791 | 0.277 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 0.530716 | 0.275 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 0.533269 | 0.273 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 0.533269 | 0.273 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 0.537704 | 0.269 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 0.542098 | 0.266 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 0.545796 | 0.263 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 0.546450 | 0.262 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 0.546450 | 0.262 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 0.548847 | 0.261 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 0.550761 | 0.259 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 0.550761 | 0.259 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 0.551401 | 0.259 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 0.559262 | 0.252 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 0.559262 | 0.252 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 0.559262 | 0.252 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 0.559718 | 0.252 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 0.562466 | 0.250 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 0.563452 | 0.249 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 0.564039 | 0.249 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 0.566448 | 0.247 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 0.567603 | 0.246 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 0.567603 | 0.246 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 0.571714 | 0.243 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 0.579821 | 0.237 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 0.579864 | 0.237 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 0.583817 | 0.234 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 0.587775 | 0.231 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 0.591696 | 0.228 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 0.591696 | 0.228 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 0.591887 | 0.228 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 0.595579 | 0.225 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 0.597076 | 0.224 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 0.599426 | 0.222 | 1 | 0 |
| Selective autophagy | R-HSA-9663891 | 0.603237 | 0.220 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 0.603237 | 0.220 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 0.605219 | 0.218 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 0.610751 | 0.214 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 0.610751 | 0.214 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 0.624740 | 0.204 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 0.625357 | 0.204 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 0.632454 | 0.199 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 0.639173 | 0.194 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 0.639418 | 0.194 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 0.642850 | 0.192 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 0.652955 | 0.185 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 0.652955 | 0.185 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 0.656259 | 0.183 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 0.657199 | 0.182 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 0.657809 | 0.182 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 0.659533 | 0.181 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 0.659533 | 0.181 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 0.659533 | 0.181 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 0.660081 | 0.180 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 0.662775 | 0.179 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 0.665986 | 0.177 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 0.665986 | 0.177 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 0.669096 | 0.175 | 1 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 0.669168 | 0.174 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 0.669168 | 0.174 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 0.682138 | 0.166 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 0.684628 | 0.165 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 0.687633 | 0.163 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 0.690609 | 0.161 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 0.693558 | 0.159 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 0.693558 | 0.159 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 0.699370 | 0.155 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 0.699370 | 0.155 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 0.703020 | 0.153 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 0.710670 | 0.148 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 0.710670 | 0.148 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 0.713428 | 0.147 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 0.715957 | 0.145 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 0.716160 | 0.145 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 0.718866 | 0.143 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 0.718866 | 0.143 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 0.724202 | 0.140 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 0.724202 | 0.140 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 0.726832 | 0.139 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 0.726832 | 0.139 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 0.729437 | 0.137 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 0.732018 | 0.135 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 0.734574 | 0.134 | 0 | 0 |
| M Phase | R-HSA-68886 | 0.739448 | 0.131 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 0.752045 | 0.124 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 0.754169 | 0.123 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 0.760639 | 0.119 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 0.765714 | 0.116 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 0.767916 | 0.115 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 0.767916 | 0.115 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 0.772326 | 0.112 | 0 | 0 |
| Disease | R-HSA-1643685 | 0.775231 | 0.111 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 0.778786 | 0.109 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 0.781457 | 0.107 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 0.785064 | 0.105 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 0.789150 | 0.103 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 0.793987 | 0.100 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 0.795004 | 0.100 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 0.795136 | 0.100 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 0.802736 | 0.095 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 0.804162 | 0.095 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 0.806605 | 0.093 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 0.810284 | 0.091 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 0.812098 | 0.090 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 0.824320 | 0.084 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 0.829313 | 0.081 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 0.835751 | 0.078 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 0.835751 | 0.078 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 0.835756 | 0.078 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 0.837323 | 0.077 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 0.838880 | 0.076 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 0.843427 | 0.074 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 0.850812 | 0.070 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 0.861865 | 0.065 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 0.863189 | 0.064 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 0.865769 | 0.063 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 0.865797 | 0.063 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 0.868357 | 0.061 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 0.868357 | 0.061 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 0.872105 | 0.059 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 0.876939 | 0.057 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 0.880444 | 0.055 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 0.880444 | 0.055 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 0.881110 | 0.055 | 1 | 0 |
| Muscle contraction | R-HSA-397014 | 0.891428 | 0.050 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 0.899221 | 0.046 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 0.900453 | 0.046 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 0.904138 | 0.044 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 0.907848 | 0.042 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 0.908733 | 0.042 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 0.910478 | 0.041 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 0.922550 | 0.035 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 0.924763 | 0.034 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 0.929002 | 0.032 | 0 | 0 |
| Translation | R-HSA-72766 | 0.929374 | 0.032 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 0.931902 | 0.031 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 0.934280 | 0.030 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 0.942578 | 0.026 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 0.952719 | 0.021 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 0.962141 | 0.017 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 0.969749 | 0.013 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 0.975096 | 0.011 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 0.982119 | 0.008 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 0.983781 | 0.007 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 0.985412 | 0.006 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 0.990875 | 0.004 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 0.995808 | 0.002 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 0.996133 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 0.996643 | 0.001 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 0.997089 | 0.001 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 0.997284 | 0.001 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 0.999959 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 0.999996 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000 | 0.000 | 1 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 1.000000 | 0.000 | 1 | 1 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 1.000000 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Attenuation phase | R-HSA-3371568 | 1.113887e-12 | 11.953 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.182188e-11 | 10.661 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.334139e-10 | 9.477 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.441047e-09 | 8.841 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.398906e-09 | 8.854 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.265049e-08 | 7.645 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.034725e-07 | 6.691 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.389540e-07 | 6.076 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.509317e-06 | 5.600 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.566828e-06 | 5.067 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 7.985294e-06 | 5.098 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.020774e-05 | 4.991 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.603051e-05 | 4.795 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.331451e-05 | 4.632 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.279360e-05 | 4.642 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 3.227438e-05 | 4.491 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.251023e-05 | 4.488 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.650221e-05 | 4.438 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.551105e-05 | 4.342 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.162675e-05 | 4.381 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 4.578752e-05 | 4.339 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.162675e-05 | 4.381 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.630227e-05 | 4.249 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.651631e-05 | 4.177 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.558837e-05 | 4.122 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.558837e-05 | 4.122 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.914311e-05 | 4.160 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.307854e-05 | 4.136 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 7.307854e-05 | 4.136 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.569708e-05 | 4.182 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.605852e-05 | 4.180 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.806829e-05 | 4.055 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 9.289887e-05 | 4.032 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 9.289887e-05 | 4.032 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.122134e-04 | 3.950 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.087427e-04 | 3.964 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.230487e-04 | 3.910 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.597400e-04 | 3.797 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.831544e-04 | 3.737 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.077511e-04 | 3.682 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.077511e-04 | 3.682 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.256710e-04 | 3.647 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.256710e-04 | 3.647 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.414328e-04 | 3.617 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.653196e-04 | 3.576 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.715125e-04 | 3.566 | 1 | 0 |
| Apoptosis | R-HSA-109581 | 2.661124e-04 | 3.575 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.649935e-04 | 3.438 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.803859e-04 | 3.420 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.582756e-04 | 3.253 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.388831e-04 | 3.269 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.624166e-04 | 3.250 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.205907e-04 | 3.284 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.586243e-04 | 3.253 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.586243e-04 | 3.253 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.586243e-04 | 3.253 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.315829e-04 | 3.274 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.732041e-04 | 3.242 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.757225e-04 | 3.240 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.961618e-04 | 3.157 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.788041e-04 | 3.168 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.317126e-04 | 3.136 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.770381e-04 | 3.110 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.908820e-04 | 3.102 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.770381e-04 | 3.110 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.333914e-04 | 3.079 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.334183e-04 | 3.079 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.032241e-04 | 3.044 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.866915e-04 | 3.006 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.887272e-04 | 3.005 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.034668e-03 | 2.985 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.163326e-03 | 2.934 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.278806e-03 | 2.893 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.390242e-03 | 2.857 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.640905e-03 | 2.785 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.575329e-03 | 2.803 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.592498e-03 | 2.798 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.592498e-03 | 2.798 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.692375e-03 | 2.772 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.868985e-03 | 2.728 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.197170e-03 | 2.658 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.879932e-03 | 2.541 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.879932e-03 | 2.541 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.879932e-03 | 2.541 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.879932e-03 | 2.541 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.879932e-03 | 2.541 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.879932e-03 | 2.541 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.879932e-03 | 2.541 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.879932e-03 | 2.541 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.879932e-03 | 2.541 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.879932e-03 | 2.541 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.879932e-03 | 2.541 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.745652e-03 | 2.561 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.744348e-03 | 2.562 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.960147e-03 | 2.529 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.960147e-03 | 2.529 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.744348e-03 | 2.562 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.630185e-03 | 2.580 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.829507e-03 | 2.548 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.932384e-03 | 2.533 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.627942e-03 | 2.580 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.827029e-03 | 2.549 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.844129e-03 | 2.546 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.897851e-03 | 2.538 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.025812e-03 | 2.519 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.223970e-03 | 2.492 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.401158e-03 | 2.468 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.401158e-03 | 2.468 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.411668e-03 | 2.467 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 4.442550e-03 | 2.352 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.442550e-03 | 2.352 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.237671e-03 | 2.373 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.450170e-03 | 2.352 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.802269e-03 | 2.319 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.253762e-03 | 2.371 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.450170e-03 | 2.352 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.450170e-03 | 2.352 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.709900e-03 | 2.327 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.801756e-03 | 2.420 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.450170e-03 | 2.352 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.415841e-03 | 2.355 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.415841e-03 | 2.355 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.442550e-03 | 2.352 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.116852e-03 | 2.385 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.220153e-03 | 2.375 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.142037e-03 | 2.383 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.415841e-03 | 2.355 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.748500e-03 | 2.426 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.450170e-03 | 2.352 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.035316e-03 | 2.394 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.218088e-03 | 2.282 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.269242e-03 | 2.278 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.870045e-03 | 2.231 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.870045e-03 | 2.231 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.303320e-03 | 2.200 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 6.315880e-03 | 2.200 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.366720e-03 | 2.196 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.778851e-03 | 2.169 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.910560e-03 | 2.160 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.290548e-03 | 2.137 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 7.340181e-03 | 2.134 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.348432e-03 | 2.134 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.387126e-03 | 2.076 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.275335e-03 | 2.033 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.150193e-03 | 2.089 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.906710e-03 | 2.050 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.476427e-03 | 2.023 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 9.507392e-03 | 2.022 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 9.562140e-03 | 2.019 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.629123e-03 | 2.016 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.711888e-03 | 2.013 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.071078e-02 | 1.970 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.071078e-02 | 1.970 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.094501e-02 | 1.961 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.199836e-02 | 1.921 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.199836e-02 | 1.921 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.200607e-02 | 1.921 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.270352e-02 | 1.896 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.316253e-02 | 1.881 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.337104e-02 | 1.874 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.413226e-02 | 1.850 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.368977e-02 | 1.864 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.637453e-02 | 1.786 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.592167e-02 | 1.798 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.623628e-02 | 1.790 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.482956e-02 | 1.829 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.585197e-02 | 1.800 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.472066e-02 | 1.832 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.667160e-02 | 1.778 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.667160e-02 | 1.778 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.667160e-02 | 1.778 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.688991e-02 | 1.772 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.730870e-02 | 1.762 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 1.787524e-02 | 1.748 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.800642e-02 | 1.745 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.845849e-02 | 1.734 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.903183e-02 | 1.721 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.965461e-02 | 1.707 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.991804e-02 | 1.701 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.991804e-02 | 1.701 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.028998e-02 | 1.693 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.113865e-02 | 1.675 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.153216e-02 | 1.667 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.218768e-02 | 1.654 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.281134e-02 | 1.642 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.321779e-02 | 1.634 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.340544e-02 | 1.631 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.340544e-02 | 1.631 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 2.340544e-02 | 1.631 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.340544e-02 | 1.631 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.340544e-02 | 1.631 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.352544e-02 | 1.628 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.460452e-02 | 1.609 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.712335e-02 | 1.567 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.054186e-02 | 1.515 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.093964e-02 | 1.509 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.494430e-02 | 1.603 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 2.712335e-02 | 1.567 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.093964e-02 | 1.509 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.748774e-02 | 1.561 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.524420e-02 | 1.598 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.949304e-02 | 1.530 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.106161e-02 | 1.508 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.182666e-02 | 1.497 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.256934e-02 | 1.487 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.293000e-02 | 1.482 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.321491e-02 | 1.479 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.339250e-02 | 1.476 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.491169e-02 | 1.457 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 3.521039e-02 | 1.453 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.521039e-02 | 1.453 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.526815e-02 | 1.453 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.662087e-02 | 1.436 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 3.825060e-02 | 1.417 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 3.825060e-02 | 1.417 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.827237e-02 | 1.417 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.856825e-02 | 1.414 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.956014e-02 | 1.403 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.956014e-02 | 1.403 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.956014e-02 | 1.403 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.956014e-02 | 1.403 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.956014e-02 | 1.403 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 4.410162e-02 | 1.356 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.372410e-02 | 1.270 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.712761e-02 | 1.327 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.170655e-02 | 1.380 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.372410e-02 | 1.270 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.287728e-02 | 1.277 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.996183e-02 | 1.301 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.461696e-02 | 1.263 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.170655e-02 | 1.380 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.882584e-02 | 1.311 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.372410e-02 | 1.270 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.600233e-02 | 1.337 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.372410e-02 | 1.270 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.454952e-02 | 1.263 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.287798e-02 | 1.368 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.706424e-02 | 1.327 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.170655e-02 | 1.380 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.505336e-02 | 1.346 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.500082e-02 | 1.347 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.846258e-02 | 1.315 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 4.475099e-02 | 1.349 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.133806e-02 | 1.384 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.372410e-02 | 1.270 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.070328e-02 | 1.295 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 5.682541e-02 | 1.245 | 0 | 0 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 5.682541e-02 | 1.245 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 5.682541e-02 | 1.245 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.682541e-02 | 1.245 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.878796e-02 | 1.231 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.878796e-02 | 1.231 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.953745e-02 | 1.225 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.210079e-02 | 1.207 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.295581e-02 | 1.201 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.325287e-02 | 1.199 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.400926e-02 | 1.194 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.533069e-02 | 1.185 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.533069e-02 | 1.185 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.537395e-02 | 1.185 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.601941e-02 | 1.180 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.863636e-02 | 1.163 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.863636e-02 | 1.163 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.863636e-02 | 1.163 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.938006e-02 | 1.159 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.938006e-02 | 1.159 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.938006e-02 | 1.159 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.938006e-02 | 1.159 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.291452e-02 | 1.137 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.489268e-02 | 1.126 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 7.504258e-02 | 1.125 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 7.504258e-02 | 1.125 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 7.504258e-02 | 1.125 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.547003e-02 | 1.122 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.552234e-02 | 1.122 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.646021e-02 | 1.117 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 9.290900e-02 | 1.032 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 9.290900e-02 | 1.032 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.104314e-01 | 0.957 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 1.104314e-01 | 0.957 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 8.631387e-02 | 1.064 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 9.220825e-02 | 1.035 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 9.220825e-02 | 1.035 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.821606e-02 | 1.008 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.043308e-01 | 0.982 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.105460e-01 | 0.956 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 8.999030e-02 | 1.046 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.220825e-02 | 1.035 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.015836e-01 | 0.993 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.071846e-01 | 0.970 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.625698e-02 | 1.064 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.053968e-02 | 1.094 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 9.821606e-02 | 1.008 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.631387e-02 | 1.064 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.821606e-02 | 1.008 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.128846e-02 | 1.040 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.105460e-01 | 0.956 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.104314e-01 | 0.957 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 1.105460e-01 | 0.956 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.626866e-02 | 1.064 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.759048e-02 | 1.011 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.053968e-02 | 1.094 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.765506e-02 | 1.010 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.259158e-02 | 1.083 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.104314e-01 | 0.957 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.015836e-01 | 0.993 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 1.178371e-01 | 0.929 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.015836e-01 | 0.993 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.085940e-01 | 0.964 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.043308e-01 | 0.982 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 8.625698e-02 | 1.064 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.104314e-01 | 0.957 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.105460e-01 | 0.956 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 9.213216e-02 | 1.036 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.157784e-01 | 0.936 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.053968e-02 | 1.094 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.003116e-01 | 0.999 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.073043e-02 | 1.042 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.178371e-01 | 0.929 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.631387e-02 | 1.064 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 8.631387e-02 | 1.064 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.367187e-02 | 1.028 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.536730e-02 | 1.021 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.043308e-01 | 0.982 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.105460e-01 | 0.956 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.103211e-01 | 0.957 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.053968e-02 | 1.094 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.168557e-01 | 0.932 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.168557e-01 | 0.932 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.505686e-02 | 1.022 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.179051e-01 | 0.928 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.179051e-01 | 0.928 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.202077e-01 | 0.920 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.226020e-01 | 0.912 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 1.232539e-01 | 0.909 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.232539e-01 | 0.909 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.232539e-01 | 0.909 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 1.444704e-01 | 0.840 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.444704e-01 | 0.840 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 1.444704e-01 | 0.840 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 1.444704e-01 | 0.840 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.444704e-01 | 0.840 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 1.444704e-01 | 0.840 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 1.444704e-01 | 0.840 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 1.444704e-01 | 0.840 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.609998e-01 | 0.793 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.609998e-01 | 0.793 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.772108e-01 | 0.752 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.772108e-01 | 0.752 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 1.772108e-01 | 0.752 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 1.772108e-01 | 0.752 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.772108e-01 | 0.752 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 1.931096e-01 | 0.714 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.931096e-01 | 0.714 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.931096e-01 | 0.714 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.931096e-01 | 0.714 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.931096e-01 | 0.714 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 2.087022e-01 | 0.680 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.087022e-01 | 0.680 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.087022e-01 | 0.680 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.087022e-01 | 0.680 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.239944e-01 | 0.650 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 2.239944e-01 | 0.650 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.239944e-01 | 0.650 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.389920e-01 | 0.622 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 2.389920e-01 | 0.622 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.297348e-01 | 0.887 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.496194e-01 | 0.825 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.496194e-01 | 0.825 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.496194e-01 | 0.825 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.631925e-01 | 0.787 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.839316e-01 | 0.735 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.909282e-01 | 0.719 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.307419e-01 | 0.884 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.395608e-01 | 0.855 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.485742e-01 | 0.828 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.496194e-01 | 0.825 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.563776e-01 | 0.806 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.406687e-01 | 0.619 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.963583e-01 | 0.707 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.563776e-01 | 0.806 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.211650e-01 | 0.655 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.276163e-01 | 0.894 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.239944e-01 | 0.650 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.839316e-01 | 0.735 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.123410e-01 | 0.673 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.121114e-01 | 0.673 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.909282e-01 | 0.719 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 2.239944e-01 | 0.650 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 1.979596e-01 | 0.703 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 2.478413e-01 | 0.606 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.496194e-01 | 0.825 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.772108e-01 | 0.752 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.769740e-01 | 0.752 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.444704e-01 | 0.840 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.406687e-01 | 0.619 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.814788e-01 | 0.741 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 1.438257e-01 | 0.842 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.335063e-01 | 0.632 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.943689e-01 | 0.711 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.943689e-01 | 0.711 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.943689e-01 | 0.711 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.444704e-01 | 0.840 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.239944e-01 | 0.650 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 2.389920e-01 | 0.622 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.362929e-01 | 0.866 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.631925e-01 | 0.787 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.909282e-01 | 0.719 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.123410e-01 | 0.673 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.337639e-01 | 0.874 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.877141e-01 | 0.727 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.087022e-01 | 0.680 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.961374e-01 | 0.707 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 1.700595e-01 | 0.769 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.192242e-01 | 0.659 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.364776e-01 | 0.626 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.324113e-01 | 0.878 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.438257e-01 | 0.842 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 1.772108e-01 | 0.752 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.239944e-01 | 0.650 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 1.496194e-01 | 0.825 | 1 | 1 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 1.700595e-01 | 0.769 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.909282e-01 | 0.719 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.979596e-01 | 0.703 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.979596e-01 | 0.703 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 2.478413e-01 | 0.606 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.478413e-01 | 0.606 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.297348e-01 | 0.887 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.263570e-01 | 0.645 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.087022e-01 | 0.680 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.264093e-01 | 0.898 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.979596e-01 | 0.703 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.121114e-01 | 0.673 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.320344e-01 | 0.879 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.274606e-01 | 0.895 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 2.211650e-01 | 0.655 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.262472e-01 | 0.645 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.276163e-01 | 0.894 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.772108e-01 | 0.752 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.389920e-01 | 0.622 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.050219e-01 | 0.688 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.121114e-01 | 0.673 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.121114e-01 | 0.673 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.307419e-01 | 0.884 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.807704e-01 | 0.743 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.351262e-01 | 0.869 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.839316e-01 | 0.735 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.478413e-01 | 0.606 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.769740e-01 | 0.752 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.909282e-01 | 0.719 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.695636e-01 | 0.771 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.769404e-01 | 0.752 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.588675e-01 | 0.799 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.444704e-01 | 0.840 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.444704e-01 | 0.840 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.772108e-01 | 0.752 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.087022e-01 | 0.680 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 2.389920e-01 | 0.622 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 1.563776e-01 | 0.806 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.839316e-01 | 0.735 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.909282e-01 | 0.719 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.909282e-01 | 0.719 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.979596e-01 | 0.703 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.478413e-01 | 0.606 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.478413e-01 | 0.606 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.222765e-01 | 0.653 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.163930e-01 | 0.665 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.706315e-01 | 0.768 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.364776e-01 | 0.626 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.383068e-01 | 0.623 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.979596e-01 | 0.703 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.406687e-01 | 0.619 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.977272e-01 | 0.704 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.467869e-01 | 0.608 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 1.609998e-01 | 0.793 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.389920e-01 | 0.622 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.362929e-01 | 0.866 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.429229e-01 | 0.845 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.121114e-01 | 0.673 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.263570e-01 | 0.645 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 2.263570e-01 | 0.645 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.043032e-01 | 0.690 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.043032e-01 | 0.690 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.693660e-01 | 0.771 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.406687e-01 | 0.619 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.811444e-01 | 0.742 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.295101e-01 | 0.639 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.307419e-01 | 0.884 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.463436e-01 | 0.835 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.307419e-01 | 0.884 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.258991e-01 | 0.900 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.335063e-01 | 0.632 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.406687e-01 | 0.619 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.389920e-01 | 0.622 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.060661e-01 | 0.686 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.961374e-01 | 0.707 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 2.192242e-01 | 0.659 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.081010e-01 | 0.682 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.362929e-01 | 0.866 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.364776e-01 | 0.626 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.700595e-01 | 0.769 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.839316e-01 | 0.735 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.050219e-01 | 0.688 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.419764e-01 | 0.616 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.263570e-01 | 0.645 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 2.389920e-01 | 0.622 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.493323e-01 | 0.603 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.537006e-01 | 0.596 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 2.537006e-01 | 0.596 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.537006e-01 | 0.596 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.575948e-01 | 0.589 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.622044e-01 | 0.581 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.622044e-01 | 0.581 | 0 | 0 |
| Translation | R-HSA-72766 | 2.656392e-01 | 0.576 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.673661e-01 | 0.573 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.681258e-01 | 0.572 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.681258e-01 | 0.572 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.681258e-01 | 0.572 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.681258e-01 | 0.572 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 2.681258e-01 | 0.572 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 2.681258e-01 | 0.572 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.681258e-01 | 0.572 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.681258e-01 | 0.572 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.681258e-01 | 0.572 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.681258e-01 | 0.572 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.681258e-01 | 0.572 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.681258e-01 | 0.572 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 2.681258e-01 | 0.572 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 2.681258e-01 | 0.572 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.681258e-01 | 0.572 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 2.681258e-01 | 0.572 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.693892e-01 | 0.570 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 2.693892e-01 | 0.570 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.693892e-01 | 0.570 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 2.707306e-01 | 0.567 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.728376e-01 | 0.564 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.728376e-01 | 0.564 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 2.765725e-01 | 0.558 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.765725e-01 | 0.558 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.765725e-01 | 0.558 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.765725e-01 | 0.558 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.765725e-01 | 0.558 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.765725e-01 | 0.558 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.780853e-01 | 0.556 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.780853e-01 | 0.556 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.786788e-01 | 0.555 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.815518e-01 | 0.550 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.822731e-01 | 0.549 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.822731e-01 | 0.549 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 2.822731e-01 | 0.549 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.822731e-01 | 0.549 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 2.822731e-01 | 0.549 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.822731e-01 | 0.549 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 2.822731e-01 | 0.549 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.823404e-01 | 0.549 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.833289e-01 | 0.548 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.837517e-01 | 0.547 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.837517e-01 | 0.547 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.837517e-01 | 0.547 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 2.837517e-01 | 0.547 | 1 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 2.837517e-01 | 0.547 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 2.837517e-01 | 0.547 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.892907e-01 | 0.539 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.909244e-01 | 0.536 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.946720e-01 | 0.531 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 2.961477e-01 | 0.528 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.961477e-01 | 0.528 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.961477e-01 | 0.528 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.961477e-01 | 0.528 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 2.961477e-01 | 0.528 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 2.961477e-01 | 0.528 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.961477e-01 | 0.528 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 2.961477e-01 | 0.528 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.980880e-01 | 0.526 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 3.052403e-01 | 0.515 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.052403e-01 | 0.515 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.052403e-01 | 0.515 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.096020e-01 | 0.509 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.097355e-01 | 0.509 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.097355e-01 | 0.509 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.097550e-01 | 0.509 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 3.097550e-01 | 0.509 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.097550e-01 | 0.509 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.097550e-01 | 0.509 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 3.097550e-01 | 0.509 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.097550e-01 | 0.509 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.097550e-01 | 0.509 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 3.097550e-01 | 0.509 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 3.097550e-01 | 0.509 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.097550e-01 | 0.509 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.097550e-01 | 0.509 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.123790e-01 | 0.505 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.150274e-01 | 0.502 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.195019e-01 | 0.496 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.195019e-01 | 0.496 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.195019e-01 | 0.496 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.231001e-01 | 0.491 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.231001e-01 | 0.491 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 3.231001e-01 | 0.491 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.231001e-01 | 0.491 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.231001e-01 | 0.491 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.266072e-01 | 0.486 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.266072e-01 | 0.486 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.266072e-01 | 0.486 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.271090e-01 | 0.485 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.271090e-01 | 0.485 | 0 | 0 |
| Disease | R-HSA-1643685 | 3.321696e-01 | 0.479 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.327947e-01 | 0.478 | 1 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.336927e-01 | 0.477 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.336927e-01 | 0.477 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 3.361879e-01 | 0.473 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 3.361879e-01 | 0.473 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.361879e-01 | 0.473 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.361879e-01 | 0.473 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.362042e-01 | 0.473 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 3.407566e-01 | 0.468 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.407566e-01 | 0.468 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.467841e-01 | 0.460 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.467841e-01 | 0.460 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.477970e-01 | 0.459 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.477970e-01 | 0.459 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.490235e-01 | 0.457 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.490235e-01 | 0.457 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 3.490235e-01 | 0.457 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.490235e-01 | 0.457 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.490235e-01 | 0.457 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.490235e-01 | 0.457 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.490235e-01 | 0.457 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 3.490235e-01 | 0.457 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 3.490235e-01 | 0.457 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 3.490235e-01 | 0.457 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 3.490235e-01 | 0.457 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.490339e-01 | 0.457 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.520685e-01 | 0.453 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.544494e-01 | 0.450 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.548124e-01 | 0.450 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.548124e-01 | 0.450 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.616116e-01 | 0.442 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 3.616116e-01 | 0.442 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.616116e-01 | 0.442 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.616116e-01 | 0.442 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 3.616116e-01 | 0.442 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.616116e-01 | 0.442 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.616116e-01 | 0.442 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.616116e-01 | 0.442 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.616116e-01 | 0.442 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.616116e-01 | 0.442 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 3.618009e-01 | 0.442 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.622026e-01 | 0.441 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.678891e-01 | 0.434 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 3.687611e-01 | 0.433 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.725169e-01 | 0.429 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.725169e-01 | 0.429 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 3.739571e-01 | 0.427 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.739571e-01 | 0.427 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.739571e-01 | 0.427 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.739571e-01 | 0.427 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 3.739571e-01 | 0.427 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.739571e-01 | 0.427 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.739571e-01 | 0.427 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.739571e-01 | 0.427 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 3.739571e-01 | 0.427 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.750972e-01 | 0.426 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.756913e-01 | 0.425 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.783156e-01 | 0.422 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 3.825903e-01 | 0.417 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 3.825903e-01 | 0.417 | 1 | 1 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 3.860457e-01 | 0.413 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.860646e-01 | 0.413 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.860646e-01 | 0.413 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.860646e-01 | 0.413 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.860646e-01 | 0.413 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.860646e-01 | 0.413 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.860646e-01 | 0.413 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 3.860646e-01 | 0.413 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.860646e-01 | 0.413 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 3.860646e-01 | 0.413 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.860646e-01 | 0.413 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 3.885009e-01 | 0.411 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.894565e-01 | 0.410 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.962888e-01 | 0.402 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 3.962888e-01 | 0.402 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.962888e-01 | 0.402 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.979387e-01 | 0.400 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 3.979387e-01 | 0.400 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.979387e-01 | 0.400 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.979387e-01 | 0.400 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.979387e-01 | 0.400 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.979387e-01 | 0.400 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.030858e-01 | 0.395 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 4.094646e-01 | 0.388 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.095838e-01 | 0.388 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.095838e-01 | 0.388 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 4.095838e-01 | 0.388 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.095838e-01 | 0.388 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.095838e-01 | 0.388 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.095838e-01 | 0.388 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.098463e-01 | 0.387 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.165693e-01 | 0.380 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.165693e-01 | 0.380 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 4.210044e-01 | 0.376 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.210044e-01 | 0.376 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.210044e-01 | 0.376 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.210044e-01 | 0.376 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 4.210044e-01 | 0.376 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.210044e-01 | 0.376 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.262371e-01 | 0.370 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.276432e-01 | 0.369 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.322048e-01 | 0.364 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 4.322048e-01 | 0.364 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.322048e-01 | 0.364 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.353903e-01 | 0.361 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.353903e-01 | 0.361 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 4.353903e-01 | 0.361 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.404824e-01 | 0.356 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.431892e-01 | 0.353 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.431892e-01 | 0.353 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 4.431892e-01 | 0.353 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.431892e-01 | 0.353 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 4.431892e-01 | 0.353 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.455570e-01 | 0.351 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.478922e-01 | 0.349 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.495850e-01 | 0.347 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.495850e-01 | 0.347 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.495850e-01 | 0.347 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 4.502092e-01 | 0.347 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.539617e-01 | 0.343 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.539617e-01 | 0.343 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.539617e-01 | 0.343 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 4.539617e-01 | 0.343 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 4.539617e-01 | 0.343 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 4.560619e-01 | 0.341 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.560619e-01 | 0.341 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 4.560619e-01 | 0.341 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.560619e-01 | 0.341 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.560619e-01 | 0.341 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.560619e-01 | 0.341 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.576429e-01 | 0.339 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 4.606691e-01 | 0.337 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 4.624949e-01 | 0.335 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.645265e-01 | 0.333 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.645265e-01 | 0.333 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 4.645265e-01 | 0.333 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.688831e-01 | 0.329 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.688831e-01 | 0.329 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.706455e-01 | 0.327 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.748875e-01 | 0.323 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.748875e-01 | 0.323 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.748875e-01 | 0.323 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.748875e-01 | 0.323 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.748875e-01 | 0.323 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.756026e-01 | 0.323 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 4.783740e-01 | 0.320 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.805384e-01 | 0.318 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.815229e-01 | 0.317 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.815229e-01 | 0.317 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 4.850487e-01 | 0.314 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.850487e-01 | 0.314 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.850487e-01 | 0.314 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.877732e-01 | 0.312 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.903439e-01 | 0.309 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.903439e-01 | 0.309 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 4.939764e-01 | 0.306 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.950139e-01 | 0.305 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.950139e-01 | 0.305 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.950139e-01 | 0.305 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.000584e-01 | 0.301 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.001318e-01 | 0.301 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.001318e-01 | 0.301 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.001318e-01 | 0.301 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.047868e-01 | 0.297 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.047868e-01 | 0.297 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.077414e-01 | 0.294 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.118255e-01 | 0.291 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.122980e-01 | 0.290 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.143711e-01 | 0.289 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.143711e-01 | 0.289 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.143711e-01 | 0.289 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.143711e-01 | 0.289 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.143711e-01 | 0.289 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.183077e-01 | 0.285 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 5.237706e-01 | 0.281 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 5.237706e-01 | 0.281 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.237706e-01 | 0.281 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.239844e-01 | 0.281 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 5.301789e-01 | 0.276 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.329887e-01 | 0.273 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.329887e-01 | 0.273 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.329887e-01 | 0.273 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.329887e-01 | 0.273 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.329887e-01 | 0.273 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.329887e-01 | 0.273 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.329887e-01 | 0.273 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.329887e-01 | 0.273 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.329887e-01 | 0.273 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.360396e-01 | 0.271 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.420289e-01 | 0.266 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.420289e-01 | 0.266 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.420289e-01 | 0.266 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.455520e-01 | 0.263 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.471565e-01 | 0.262 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.476100e-01 | 0.262 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.476100e-01 | 0.262 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.508947e-01 | 0.259 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.508947e-01 | 0.259 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 5.508947e-01 | 0.259 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 5.508947e-01 | 0.259 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.508947e-01 | 0.259 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.508947e-01 | 0.259 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.533191e-01 | 0.257 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 5.533191e-01 | 0.257 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.556772e-01 | 0.255 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.589773e-01 | 0.253 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 5.589773e-01 | 0.253 | 1 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.589773e-01 | 0.253 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 5.595598e-01 | 0.252 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.645844e-01 | 0.248 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.645844e-01 | 0.248 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 5.672699e-01 | 0.246 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 5.681162e-01 | 0.246 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.681162e-01 | 0.246 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.681162e-01 | 0.246 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.681162e-01 | 0.246 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.701403e-01 | 0.244 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.756448e-01 | 0.240 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 5.756448e-01 | 0.240 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.756448e-01 | 0.240 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.764785e-01 | 0.239 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.764785e-01 | 0.239 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.829135e-01 | 0.234 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.846794e-01 | 0.233 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.846794e-01 | 0.233 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 5.846794e-01 | 0.233 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.846794e-01 | 0.233 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.899467e-01 | 0.229 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.918491e-01 | 0.228 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.918491e-01 | 0.228 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 5.918491e-01 | 0.228 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 5.918491e-01 | 0.228 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.927220e-01 | 0.227 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 5.927220e-01 | 0.227 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.927220e-01 | 0.227 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 5.927220e-01 | 0.227 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.927220e-01 | 0.227 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 5.971474e-01 | 0.224 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.006093e-01 | 0.221 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.006093e-01 | 0.221 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.006093e-01 | 0.221 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.006093e-01 | 0.221 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.006093e-01 | 0.221 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.032007e-01 | 0.220 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.043346e-01 | 0.219 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.075890e-01 | 0.216 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.083444e-01 | 0.216 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 6.083444e-01 | 0.216 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 6.083444e-01 | 0.216 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.127325e-01 | 0.213 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.127325e-01 | 0.213 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.159301e-01 | 0.210 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.159301e-01 | 0.210 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.159301e-01 | 0.210 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.159301e-01 | 0.210 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 6.178244e-01 | 0.209 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.178244e-01 | 0.209 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.190761e-01 | 0.208 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.228649e-01 | 0.206 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.233694e-01 | 0.205 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 6.233694e-01 | 0.205 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.250186e-01 | 0.204 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.278539e-01 | 0.202 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.306650e-01 | 0.200 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.327917e-01 | 0.199 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.376783e-01 | 0.195 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.376783e-01 | 0.195 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.378197e-01 | 0.195 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 6.378197e-01 | 0.195 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.378197e-01 | 0.195 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.378197e-01 | 0.195 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.425139e-01 | 0.192 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.425139e-01 | 0.192 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.448363e-01 | 0.191 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.448363e-01 | 0.191 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.472986e-01 | 0.189 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.517174e-01 | 0.186 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.520325e-01 | 0.186 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.527140e-01 | 0.185 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.565492e-01 | 0.183 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.567158e-01 | 0.183 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.567158e-01 | 0.183 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 6.584655e-01 | 0.181 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.584655e-01 | 0.181 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.613488e-01 | 0.180 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.650833e-01 | 0.177 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.650833e-01 | 0.177 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.678723e-01 | 0.175 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.704643e-01 | 0.174 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.715733e-01 | 0.173 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.749473e-01 | 0.171 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.752688e-01 | 0.171 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.793807e-01 | 0.168 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.841796e-01 | 0.165 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 6.896971e-01 | 0.161 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.903007e-01 | 0.161 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.903007e-01 | 0.161 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.910504e-01 | 0.160 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.922348e-01 | 0.160 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.963035e-01 | 0.157 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.963035e-01 | 0.157 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.963035e-01 | 0.157 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 6.963035e-01 | 0.157 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.073953e-01 | 0.150 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.079634e-01 | 0.150 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.079634e-01 | 0.150 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.090479e-01 | 0.149 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.136249e-01 | 0.147 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.136249e-01 | 0.147 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.136249e-01 | 0.147 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.246218e-01 | 0.140 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 7.299613e-01 | 0.137 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.299613e-01 | 0.137 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 7.299613e-01 | 0.137 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.299613e-01 | 0.137 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.305147e-01 | 0.136 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.351977e-01 | 0.134 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.351977e-01 | 0.134 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.351977e-01 | 0.134 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.403328e-01 | 0.131 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.426023e-01 | 0.129 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.474262e-01 | 0.126 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.503071e-01 | 0.125 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.510153e-01 | 0.124 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.510153e-01 | 0.124 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.517898e-01 | 0.124 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 7.551501e-01 | 0.122 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.551501e-01 | 0.122 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.615210e-01 | 0.118 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 7.645570e-01 | 0.117 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.651311e-01 | 0.116 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.691245e-01 | 0.114 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.691245e-01 | 0.114 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.691245e-01 | 0.114 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.718737e-01 | 0.112 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 7.736037e-01 | 0.111 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.736037e-01 | 0.111 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.813864e-01 | 0.107 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.823037e-01 | 0.107 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.865280e-01 | 0.104 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 7.865280e-01 | 0.104 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.865280e-01 | 0.104 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 7.865280e-01 | 0.104 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.906705e-01 | 0.102 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.907065e-01 | 0.102 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 7.947329e-01 | 0.100 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.987167e-01 | 0.098 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.987167e-01 | 0.098 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 7.987167e-01 | 0.098 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.058072e-01 | 0.094 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.064545e-01 | 0.093 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 8.138958e-01 | 0.089 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.175088e-01 | 0.088 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.210519e-01 | 0.086 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.245264e-01 | 0.084 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 8.245264e-01 | 0.084 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.245264e-01 | 0.084 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.312749e-01 | 0.080 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.411676e-01 | 0.075 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 8.440057e-01 | 0.074 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.446838e-01 | 0.073 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.528620e-01 | 0.069 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.610419e-01 | 0.065 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.640234e-01 | 0.063 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.692571e-01 | 0.061 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.692571e-01 | 0.061 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 8.708656e-01 | 0.060 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.765059e-01 | 0.057 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 8.766813e-01 | 0.057 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.767335e-01 | 0.057 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 8.778406e-01 | 0.057 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.814794e-01 | 0.055 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.892035e-01 | 0.051 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.892035e-01 | 0.051 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.892035e-01 | 0.051 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.946519e-01 | 0.048 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.979221e-01 | 0.047 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 9.006837e-01 | 0.045 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.026121e-01 | 0.044 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.045067e-01 | 0.044 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.084251e-01 | 0.042 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.117245e-01 | 0.040 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.191203e-01 | 0.037 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.199866e-01 | 0.036 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.199866e-01 | 0.036 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.230714e-01 | 0.035 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.230714e-01 | 0.035 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.353580e-01 | 0.029 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.355498e-01 | 0.029 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.355498e-01 | 0.029 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.355498e-01 | 0.029 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.449364e-01 | 0.025 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.500974e-01 | 0.022 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.510703e-01 | 0.022 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.558712e-01 | 0.020 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.570092e-01 | 0.019 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.606008e-01 | 0.017 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.628622e-01 | 0.016 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.642974e-01 | 0.016 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.649942e-01 | 0.015 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.663472e-01 | 0.015 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.676482e-01 | 0.014 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.676482e-01 | 0.014 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.681402e-01 | 0.014 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.688990e-01 | 0.014 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.724506e-01 | 0.012 | 1 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.741116e-01 | 0.011 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.759334e-01 | 0.011 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.790389e-01 | 0.009 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.862069e-01 | 0.006 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.866929e-01 | 0.006 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.885317e-01 | 0.005 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.926515e-01 | 0.003 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.955665e-01 | 0.002 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.956096e-01 | 0.002 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.971638e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.975719e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.988643e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.997880e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999794e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 1 | 0 |